Аrgon-oxygen breathing mixture
Phase 3Small molecule
Аrgon-oxygen breathing mixture is one of 9 small molecule programs targeting Recovery. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
12 competitors in Recovery
#DrugCompanyPhaseTrials
1Neurontin
VViatris Specialty LLC
Approved
Epidiolex
Jazz PharmaceuticalsPhase 3
N-Acetyl-L-Cysteine
PPeking University People's Hospital
Phase 2
Аrgon-oxygen breathing mixture
NNegovsky Reanimatology Research Institute
Phase 3
BXCL501
BBioXcel Therapeutics Inc
Phase 2
Blood Collection
AAssistance Publique - Hôpitaux de Paris
Preclinical
Bupivacaine-Fentanyl
SSamuel Lunenfeld Research Institute, Mount Sinai Hospital
Preclinical
Dual NRT
MMassachusetts General Hospital
Preclinical
L-Tyrosine
DDirection Centrale du Service de Santé des Armées
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details